Intensity Therapeutics, Inc. Common stock (NASDAQ: INTS) last traded at $3.31, down 8.82% on the session. The quote above updates while this page is open; the figures below are drawn from Intensity Therapeutics, Inc. Common stock’s own filings and are restated only when a new one is published.
Intensity Therapeutics, Inc. Common stock trades on NASDAQ under the ticker INTS. Its market capitalisation is $10.81 million.
Valuation measures for Intensity Therapeutics, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.81M |
|---|---|
| Enterprise value | $3.58M |
| Price / book | 1.17 |
| Beta | -1.62 |
Trailing-twelve-month figures tagged in Intensity Therapeutics, Inc. Common stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$11.16M |
| Return on equity | -121.15% |
|---|
| Cash | $9.53M |
|---|
Range and volume for INTS over the past 52 weeks.
| 52-week high | $43.50 |
|---|---|
| 52-week low | $3.14 |
| Volume | 41.3K |
| Average volume | 25.7K |
| Previous close | $3.63 |
Invest a chosen dollar amount in Intensity Therapeutics, Inc. Common stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell INTS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.